Purchases and Sales Made in Q4 2022 in Seres Therapeutics, Inc. (MCRB)
This table provides information about the institutional ownership of Seres Therapeutics, Inc. (MCRB) during Q4 2022. The information is specifically focused on institutions that hold shares of Seres Therapeutics, Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Feb 13, 2023
Q4 2022
|
Jpmorgan Chase & CO
New York, NY |
SELL
|
- |
-97.8K- 13.77% |
$498K - $885K
|
613K
$496K
|
|
|
Feb 14, 2023
Q4 2022
|
Nuveen Asset Management, LLC
Chicago, IL |
SELL
|
- |
-160K- 34.5% |
$816K - $1.45M
|
304K
$247K
|
|
|
Feb 14, 2023
Q4 2022
|
Steven Cohen
Point72 Asset Management, L.P. | Stamford, Ct
|
SELL
|
- |
-240K- 25.53% |
$1.22M - $2.17M
|
700K
$567K
|
|
|
Feb 13, 2023
Q4 2022
|
Federated Hermes, Inc.
Pittsburgh, PA |
SELL
|
- |
-413K- 2.23% |
$2.1M - $3.74M
|
18.1M
$14.6M
|
|
|
Feb 10, 2023
Q4 2022
|
Vanguard Group Inc
Valley Forge, PA |
SELL
|
- |
-518K- 7.83% |
$2.64M - $4.69M
|
6.09M
$4.94M
|
|
|
Feb 13, 2023
Q4 2022
|
Invesco Ltd.
Atlanta, GA |
SELL
|
- |
-535K- 94.0% |
$2.73M - $4.85M
|
34.2K
$27.7K
|